Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes (RAISE)
This study has been completed.
Daiichi Sankyo Co., Ltd.
First Posted: December 18, 2007
Last Update Posted: February 9, 2009
Information provided by:
Daiichi Sankyo, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2009|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|